Hester Bios

22
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,649.00
17.95 (1.1%)
BSENSE

Dec 05

BSE+NSE Vol: 3.75 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
311.00
304.00
266.00
235.00
214.00
183.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
311.00
304.00
266.00
235.00
214.00
183.00
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
8.00
-5.00
-10.00
3.00
-16.00
Raw Materials Consumed
81.00
87.00
82.00
75.00
46.00
44.00
Power & Fuel Cost
13.00
15.00
12.00
10.00
7.00
8.00
Employee Cost
62.00
64.00
56.00
45.00
38.00
40.00
Operating Expenses
16.00
16.00
9.00
7.00
6.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
28.00
25.00
26.00
17.00
14.00
18.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
9.00
5.00
5.00
6.00
7.00
6.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
250.00
250.00
215.00
175.00
145.00
127.00
Operating Profit (PBDIT) excl Other Income
61.00
53.00
50.00
59.00
68.00
55.00
Other Income
3.00
10.00
15.00
13.00
4.00
6.00
Operating Profit (PBDIT)
64.00
64.00
65.00
73.00
73.00
61.00
Interest
12.00
19.00
9.00
4.00
6.00
7.00
Profit before Depriciation and Tax
52.00
44.00
56.00
69.00
66.00
54.00
Depreciation
16.00
17.00
20.00
16.00
13.00
13.00
Profit Before Taxation & Exceptional Items
35.00
27.00
35.00
53.00
53.00
41.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
39.00
31.00
40.00
53.00
50.00
41.00
Provision for Tax
10.00
10.00
12.00
14.00
15.00
10.00
Profit After Tax
24.00
16.00
23.00
39.00
34.00
31.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
215.00
203.00
184.00
154.00
125.00
103.00
Profit Available for appropriations
242.00
221.00
211.00
193.00
159.00
133.00
Appropriations
242.00
221.00
211.00
193.00
159.00
133.00
Equity Dividend (%)
70.00%
60.00%
80.00%
100.00%
100.00%
66.00%
Earnings Per Share
33.89
24.88
31.30
46.41
40.79
34.29
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.15% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 13.79% vs 6.02% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -35.76% vs 112.18% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 49.34% vs -29.92% in Mar 2024

Compare Profit and Loss Results of Hester Bios
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
311.00
0
311.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
311.00
0
311.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
0
6.00
0%
Raw Materials Consumed
81.00
0
81.00
0%
Power & Fuel Cost
13.00
0
13.00
0%
Employee Cost
62.00
0
62.00
0%
Operating Expenses
16.00
0
16.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
28.00
0
28.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
9.00
0
9.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
250.00
0
250.00
0%
Operating Profit (PBDIT) excl Other Income
61.00
0.00
61.00
0%
Other Income
3.00
0
3.00
0%
Operating Profit (PBDIT)
64.00
0
64.00
0%
Interest
12.00
0
12.00
0%
Profit before Depriciation and Tax
52.00
0
52.00
0%
Depreciation
16.00
0
16.00
0%
Profit Before Taxation & Exceptional Items
35.00
0
35.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
39.00
0
39.00
0%
Provision for Tax
10.00
0
10.00
0%
Profit After Tax
24.00
0
24.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
215.00
0
215.00
0%
Profit Available for appropriations
242.00
0
242.00
0%
Appropriations
242.00
0
242.00
0%
Equity Dividend (%)
70%
0%
70.00
Earnings Per Share
33.89
0
33.89
0%
Profit And Loss - Net Sales
Net Sales 311.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.15% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.79% vs 6.02% in Mar 2024

Profit And Loss - Interest
Interest 12.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -35.76% vs 112.18% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 49.34% vs -29.92% in Mar 2024